Financials China Biotech Services Holdings Limited

Equities

8037

BMG2152F1014

Healthcare Facilities & Services

Delayed Hong Kong S.E. 04:08:20 2024-04-26 am EDT 5-day change 1st Jan Change
0.285 HKD +1.79% Intraday chart for China Biotech Services Holdings Limited +7.55% -62.99%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,824 1,241 1,256 1,329 1,108 741.7
Enterprise Value (EV) 1 1,672 1,237 976.4 1,244 1,097 770
P/E ratio -26.8 x -12.4 x 41.7 x 68.7 x 4.29 x -7.77 x
Yield - - - - 0.87% -
Capitalization / Revenue 25.9 x 21 x 1.92 x 2.13 x 0.6 x 3.5 x
EV / Revenue 23.8 x 20.9 x 1.49 x 1.99 x 0.59 x 3.63 x
EV / EBITDA -28.4 x -18.1 x 4.34 x 5.08 x 1.22 x -10.7 x
EV / FCF 194 x -524 x 3.88 x 49.2 x 5.83 x 14.3 x
FCF Yield 0.52% -0.19% 25.7% 2.03% 17.1% 7%
Price to Book 5.63 x 4.29 x 3.66 x 3.36 x 1.84 x 1.6 x
Nbr of stocks (in thousands) 935,347 969,806 966,046 963,231 963,231 963,231
Reference price 2 1.950 1.280 1.300 1.380 1.150 0.7700
Announcement Date 3/28/19 3/30/20 3/29/21 3/31/22 3/29/23 4/1/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 70.3 59.21 655.8 623.8 1,852 212
EBITDA 1 -58.9 -68.34 224.9 245 900.8 -72.16
EBIT 1 -67.14 -81.73 195.3 189.5 845.1 -116.9
Operating Margin -95.51% -138.03% 29.79% 30.39% 45.64% -55.13%
Earnings before Tax (EBT) 1 -69.24 -109.6 202.8 180.7 862.8 -142
Net income 1 -64.25 -98.84 30.17 19.38 258.1 -95.45
Net margin -91.39% -166.93% 4.6% 3.11% 13.94% -45.03%
EPS 2 -0.0729 -0.1029 0.0312 0.0201 0.2679 -0.0991
Free Cash Flow 1 8.624 -2.36 251.4 25.28 188 53.89
FCF margin 12.27% -3.99% 38.33% 4.05% 10.15% 25.42%
FCF Conversion (EBITDA) - - 111.79% 10.32% 20.87% -
FCF Conversion (Net income) - - 833.26% 130.43% 72.83% -
Dividend per Share - - - - 0.0100 -
Announcement Date 3/28/19 3/30/20 3/29/21 3/31/22 3/29/23 4/1/24
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - 28.3
Net Cash position 1 152 4.63 279 85.1 11 -
Leverage (Debt/EBITDA) - - - - - -0.3923 x
Free Cash Flow 1 8.62 -2.36 251 25.3 188 53.9
ROE (net income / shareholders' equity) -24.4% -34% 40.6% 27.1% 109% -21.4%
ROA (Net income/ Total Assets) -13.1% -13.5% 18.5% 14.7% 48.5% -6.85%
Assets 1 490.8 729.8 163.2 131.8 531.9 1,394
Book Value Per Share 2 0.3500 0.3000 0.3600 0.4100 0.6300 0.4800
Cash Flow per Share 2 0.1700 0.0500 0.4000 0.1600 0.1000 0.0700
Capex 1 6.5 7.35 127 12.2 108 62.9
Capex / Sales 9.24% 12.41% 19.3% 1.96% 5.84% 29.66%
Announcement Date 3/28/19 3/30/20 3/29/21 3/31/22 3/29/23 4/1/24
1HKD in Million2HKD
Estimates
  1. Stock Market
  2. Equities
  3. 8037 Stock
  4. Financials China Biotech Services Holdings Limited